日照治疗羊羔疯好办法-【济南癫痫病医院】,NFauFwHg,威海小儿羊羔疯病治疗疗法,聊城癫痫医院哪个权威,聊城癫痫病医院在线预约,日照那家癫痫医院评价高,全国看癫痫哪家,山东早期癫痫症状有什么表现
日照治疗羊羔疯好办法山东看癫痫病哪个医院好,济南治疗襄阳哪家医院好,江苏中医治疗羊羔疯哪家好,山东癫痫医院排行榜,威海哪里医院治疗羊羔疯病好,山东哪家的医院治羊羔疯病好,聊城癫痫会治好吗
World leaders in obesity research are optimistic about new guidelines out of Canada, which take a more holistic approach to diagnosing and treating obesity.One critical point is for doctors to stop relying on a person's body mass index alone for diagnosis.“Body mass index tells me how big you are. It doesn't tell me how sick you are,” said Dr. Arya Sharma, Scientific Director of Obesity Canada. “So, you can have two people with the exact same BMI numbers, two people, they are both 35, one person has sleep apnea, diabetes, hypertension, fatty liver disease, infertility whatever, and the next person with that body mass index has none of those problems.”Sharma says under these new guidelines, they are concerned that more people could be classified as obese. A person might fall under the BMI number for obesity but still have weight-related health issues.Currently, about 30% of Canadians are obese. In the United States, it’s about 42%.The head of the U.S. National Center for Weight and Wellness applauds the new approach.“That very well may be lead to a seminal shift in how the general medical population addresses obesity and for that, I think they really deserve a lot of credit,” said Dr. Scott Kahan, Director of the National Center for Weight and Wellness.Another critical issue the new guidelines address is weight bias among health professionals and people living with obesity.“Patients also tend to blame themselves, so they have an internalized weight bias, so the patients also think, ‘so this is my fault and I’ve done this to myself,’” said Sharma.Doctors say your body fights back against weight loss biologically, which is why Sharma says obesity is a chronic disease for which there is no cure but can be managed. And today, there are more proven treatments than ever, not diets.“The only reason why medication and surgery have much better long-term results is because they actually change the biology in the sense to make it much harder for the body to defend its weight,” said Sharma.Obesity is a complex disease that can be caused by genetics, psychological or environmental factors among others. 2133
in his Halloween display, he can't even count them all.He's been at this since 2015, each year growing his show at 3031 Gold Dust St. in Plainfield Township just a little more. 178
demonstrating in the memory of George Floyd.The incident took place in the Flatbush neighborhood of Brooklyn on Saturday. Protesters, separated by only a barricade, surrounded at least two NYPD SUVs, some of them throwing objects at the cars. Videos show at least one of the cars driving into the protesters. It's unclear if anyone was injured during the incident.Demonstrations have been taking place across the country this week in the wake of Floyd's death, as tensions boil over between police and communities of color.Floyd, who is black, died on Memorial Day after a white police officer 596
With over 160 vaccines in development, the race to defeat COVID-19 continues.A California company hopes to deliver its vaccine to your mailbox; one that is pain-free and doesn't require a needle and syringe."One of the things I wanted to do was make vaccines more patient-friendly, so they don't hurt and you're not afraid to take them," said Dr. Dan Henderson, a virologist and the CEO of Verndari, Inc.The biopharmaceutical company is based in Napa, California. Dr. Henderson originally came to the wine country to retire but stepped back into the lab during the Ebola crisis. He says some adults avoid vaccines because of a fear of needles, so Verndari set out to do something different. They created the VaxiPatch, a single-dose vaccination kit that uses a dermal patch with a metal microneedle array to deliver vaccines. Once applied, the person wears the patch like a Band-Aid for five minutes. The vaccine uses the COVID-19 "spike" protein that enables the virus to infect human cells and works to enhance a person's immune person.Unlike traditional vaccines, the patch doesn't need to be refrigerated, which Henderson says would make it easier and cheaper to send to developing countries. The company initially set out to make a flu vaccine but switched gears during the pandemic; they continue to adapt to the world's changing needs. "Now, for the First World, it's a shelter-in-place vaccine," said Henderson.They're working with the FDA to see if it could be mailed to your home. The vaccine would leave a temporary blue mark so the patient could take a photo and send it to their health care provider as proof of vaccination. In collaboration with the UC Davis, they've begun clinical trials in animals. Dr. Henderson says so far the results are promising.Other researchers are also working on getting a patch like this on people's arms.Scientists at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center have created a fingertip-sized skin patch that is also showing promising results in animal testing. Verndari hopes to test its vaccine in humans in the fall, and if all goes well, it could be made available to the public early next year. Dr. Henderson believes they could manufacture about 20 million doses a month. "It would mean a lot because it's important to me to make a contribution and a contribution like that, to me, is priceless." 2408
Friday that trace levels of a cancer-causing substance have been found in Zantac and other heartburn medicines.According to the FDA, low levels of N-nitrosodimethylamine, or NDMA, were found in the drug Ranitidine, a medicine used to treat extreme heartburn and acid reflux. Zantac is name-brand Ranitidine drug.The FDA says that consumers should continue to take Zantac and similar drugs while it continues its investigation, and anyone who feels they should stop taking the drug should speak to a doctor first.The FDA says it is currently "evaluating the risk to patients" and will provide more information as it becomes available.In July 2018, the FDA discovered NDMA in some blood pressure medications, prompting a recall. 730